Improved Surveillance for Colorectal Cancer

Los Angeles, CA

N/A

Recruiting

Led By Folasade P May

Research Sponsored by Jonsson Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients age 45 to 75 diagnosed with a HRN during the pre-specified two-year HRN diagnosis period

Patients between age 45 and 75 with a HRN diagnosis in the past 5 years

Must not have

Individuals with a personal history of colorectal carcinoma (CRC), inflammatory bowel disease (Crohn's, ulcerative colitis), or polyposis syndrome

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 3.5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to improve colonoscopy surveillance for patients with high-risk colon polyps by implementing interventions at the clinic, provider, and patient levels. The goal is to increase the uptake of recommended repeat

See full description

Who is the study for?

This trial is for patients with high-risk colon polyps, who are at increased risk for colorectal cancer. It aims to improve their adherence to recommended repeat colonoscopies every three years to lower their cancer risk.Check my eligibility

What is being tested?

The study tests a multilevel intervention that targets clinics, healthcare providers, and patients themselves. The goal is to enhance the rate of timely follow-up colonoscopy screenings in individuals with high-risk polyps.See study design

What are the potential side effects?

Since this trial involves interviews and communication interventions rather than medical treatments or drugs, there are no typical side effects associated with medications. However, participants may experience discomfort discussing personal health information.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 45 and 75 years old and was diagnosed with HRN within the last two years.

show original

Select...

I am between 45 and 75 years old and was diagnosed with HRN within the last 5 years.

show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a history of colorectal cancer, Crohn's, ulcerative colitis, or polyposis syndrome.

show original

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 3.5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 3.5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3.5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Completion of surveillance colonoscopy (Aim 2)

Cost effectiveness (Aim 3b)

Implementation quality (Aim 3a)

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I(Multilevel intervention)Experimental Treatment2 Interventions

Aim 1: Participants complete an interview over 20-30 minutes. Aim 2: Clinics have the automatic addition of HRN to the medical problem list and indication of surveillance interval is added to the health maintenance portion of the electronic health records (EHR). Clinics also call patients to schedule their colonoscopy. Providers receive reminders and pending orders for the colonoscopy in the electronic health record. Patients receive a reminder 6 months in advance via their patient portal and mail to schedule a colonoscopy, and also receive a phone call from the patient communication center.

Group II: Arm II (Standard follow up)Active Control2 Interventions

Patients receive care according to the clinics' usual care practices.

0 / 3Eligibility criteria met